Fact Sheet for Healthcare Providers: BioCheck SARS-CoV-2 IgM Antibody Test Kit | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: BioCheck SARS-CoV-2 IgM Antibody Test Kit

09/09/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 9/9/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BioCheck SARS-CoV-2 IgM Antibody Test Kit. The BioCheck SARS-CoV-2 IgM Antibody Test Kit is authorized for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum. (PDF)